F10 and cancer: A meta-analysis by Frere et al. [69] incorporated six randomized controlled trials—Hokusai VTE Cancer, ADAM-VTE, SELECT-D, CASTA DIVA, CARAVAGGIO, and CANVAS [70,71,72,73,74,75]—including 3690 patients (male sex, 52%), aged a mean of 67 years, and comparing FXa inhibitors with LMWHs (1850 randomized to the DOACs arms and 1840 randomized to the LMWHs arms).